e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Differences in symptoms that precede an exacerbation that influence treatment decisions
N. Hanania, A. Anzueto, A. Emmett, G. Crater (Houston, TX, San Antonio, TX, RTP, NC, United States Of America)
Source:
Annual Congress 2008 - COPD
Session:
COPD
Session type:
E-Communication Session
Number:
4667
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Hanania, A. Anzueto, A. Emmett, G. Crater (Houston, TX, San Antonio, TX, RTP, NC, United States Of America). Differences in symptoms that precede an exacerbation that influence treatment decisions. Eur Respir J 2008; 32: Suppl. 52, 4667
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Does the duration of symptoms pre admission influence the clinical course of the exacerbation in COPD?
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004
Asthma patients adjust their maintenance treatment late in response to worsening asthma symptoms
Source: Eur Respir J 2005; 26: Suppl. 49, 7s
Year: 2005
Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 199s
Year: 2002
Delayed adjustment in maintenance therapy in patients with worsening asthma symptoms
Source: Eur Respir J 2006; 28: Suppl. 50, 317s
Year: 2006
Predicting treatment outcomes following an exacerbation of airways disease
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Differences in medication adherence in chronic cbstructive pulmonary disease associated with beliefs on medications
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Effect of treatment on morning symptoms in COPD. Correlation between doctors and patients in the evaluation of symptoms. SINCON Study
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients?
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018
Using characteristics of asthma phenotypes to determine exacerbation severity
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Factors that affect the treatment of patients with asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010
Differences in asthma morbidity outcomes according to the disease initial severity
Source: Eur Respir J 2003; 22: Suppl. 45, 297s
Year: 2003
Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 261s
Year: 2002
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Impact of physical activity level on symptomatology and functionality during an acute exacerbation in COPD patients.
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018
Do COPD patients take timely measures in periods of symptom deterioration?
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept